Impact of continuous subcutaneous insulin infusion (CSII) therapy on retinopathy in patients with Type 1 diabetes

被引：0
|
作者：
Khan, I. [1 ]
Hopley, D. [1 ]
Glover, L. [1 ]
Bett, S. [1 ]
Young, S. [1 ]
Ratcliffe, J. [1 ]
Martin, P. [1 ]
Krishnan, S. [1 ]
Bharaj, H. [1 ]
Banerjee, M. [1 ]
机构：
[1] Royal Bolton Hosp, Dept Diabet & Endocrinol, Bolton, England
来源：
DIABETIC MEDICINE | 2019年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P121
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
    Allen B. King
    Akio Kuroda
    Munehide Matsuhisa
    Todd Hobbs
    Current Diabetes Reports, 2016, 16
  • [32] An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes
    Schiaffini, R
    Ciampalini, P
    Spera, S
    Cappa, M
    Crinó, A
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (04) : 347 - 352
  • [33] Continuous subcutaneous insulin infusion (CSII) therapy for children and adolescents in routine diabetes care
    Maniatis, AK
    Klingensmith, GJ
    Walravens, PA
    Mowry, CJ
    Chase, HP
    DIABETES, 2000, 49 : A361 - A361
  • [34] Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
    Lyu, Fu-ping
    Huang, Bing-kun
    Su, Wei-juan
    Yan, Fang-fang
    Zeng, Jin-yang
    Chen, Zheng
    Zhang, Yu-xian
    Wang, Shun-hua
    Huang, Yin-xiang
    Zhang, Mu-lin
    Shi, Xiu-lin
    Lin, Ming-zhu
    Li, Xue-jun
    DIABETES THERAPY, 2020, 11 (03) : 701 - 710
  • [35] Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
    Fu-ping Lyu
    Bing-kun Huang
    Wei-juan Su
    Fang-fang Yan
    Jin-yang Zeng
    Zheng Chen
    Yu-xian Zhang
    Shun-hua Wang
    Yin-xiang Huang
    Mu-lin Zhang
    Xiu-lin Shi
    Ming-zhu Lin
    Xue-jun Li
    Diabetes Therapy, 2020, 11 : 701 - 710
  • [36] Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus
    Luisa Casas-Onate, Maria
    Montoya-Martinez, Dolores
    ENFERMERIA CLINICA, 2010, 20 (04): : 216 - 221
  • [37] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) THERAPY IN PRESCHOOL CHILDREN
    Levy-Shraga, Y.
    Lerner-Geva, L.
    Modan-Moses, D.
    Graph-Barel, C.
    Mazor-Aronovitch, K.
    Boyko, V.
    Pinhas-Hamiel, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A45 - A46
  • [38] Transitioning patients with type 1 diabetes from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII)
    Kumar, RP
    Hirsch, IB
    DIABETES, 2004, 53 : A110 - A110
  • [39] A prospective study using Continuous Subcutaneous Insulin Infusion (CSII) for Type 1 diabetes in a single centre
    Solomon, A. M.
    Nethaji, C.
    Holland, J.
    Vanderpump, M.
    Press, M.
    DIABETIC MEDICINE, 2008, 25
  • [40] GLYCEMIC CONTROL AND PREGNANCY OUTCOME IN WOMEN WITH TYPE 1 DIABETES ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII)
    Cokolic, M.
    Krajnc, M.
    Zavratnik, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A51 - A52
12345